M&A faces global uncertainty as regulators ponder impact on markets overturned by Covid-19

Introduction

Date: 15 May 2020. Duration: 18:06

The Covid-19 pandemic has wreaked regulatory havoc around the globe, with the agencies responsible for reviewing mergers and acquisitions facing problems on two fronts. First up, the logistical challenges: Officials working from home may struggle to gain access to the material they need to finalize their review and interested parties may not be able to submit key information. But even more disruptive is the coronavirus’s impact on the markets. How can a regulator assess a deal’s impact on competition when the relevant market has been turned upside down by the lockdown?

Related stories:

US merger freeze unlikely, but Congress could push back timelines

Air Canada-Transat merger review exposes impossible task facing EU regulators